Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
Objective: To perform a cost-effectiveness analysis of donepezil and rivastigmine therapy for mild and moderate Alzheimer’s disease (AD) from the perspective of the Brazilian Unified Health System. Method: A hypothetical cohort of 1,000 individuals of both sexes, aged >65 years, and diagnosed wi...
Main Authors: | Luciana R. da Silva, Cid M.M. Vianna, Gabriela B.G. Mosegui, Antônio A.F. Peregrino, Valeska Marinho, Jerson Laks |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Psiquiatria (ABP)
2018-11-01
|
Series: | Brazilian Journal of Psychiatry |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462018005009101&lng=en&tlng=en |
Similar Items
-
Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer’s disease dementia: a cross-sectional survey
by: Ganesh Gopalakrishna, et al.
Published: (2023-10-01) -
Practical psychiatry of old age /
by: Wattis, John P., 1949-, et al.
Published: (2006) -
Effect of traumatic brain injury on mild behavioral impairment domains prior to all‐cause dementia diagnosis and throughout disease progression
by: Michael J. C. Bray, et al.
Published: (2022-01-01) -
Editorial: Reviews in psychiatry 2022: aging psychiatry
by: Shaheen E. Lakhan
Published: (2023-05-01) -
Emergency department interventions and their effect on delirium's natural course: The folly may be in the foley
by: Christopher B Noel, et al.
Published: (2019-01-01)